Multiple sclerosis as an adverse drug reaction: clues from the FDA Adverse Event Reporting System

Possible relationship between drug exposure and multiple sclerosis (MS) development is insufficiently investigated, and further challenged by the incomplete understanding of MS etiopathogenesis. The study aims to investigate whether drug exposure could contribute to MS, by analyzing worldwide spontaneous reporting archives of adverse drug reaction (ADRs).



Titolo: Multiple sclerosis as an adverse drug reaction: clues from the FDA Adverse Event Reporting System
Autore/i: Antonazzo, Ippazio Cosimo; Raschi, Emanuel; Forcesi, Emanuele; Riise, Trond; Bjornevik, Kjetil; Baldin, Elisa; De Ponti, Fabrizio; Poluzzi, Elisabetta
Autore/i Unibo: 
ANTONAZZO, IPPAZIO COSIMO  
RASCHI, EMANUEL  
FORCESI, EMANUELE  
BALDIN, ELISA  
DE PONTI, FABRIZIO  
POLUZZI, ELISABETTA  
mostra contributor esterni 
Anno: 2018
Rivista: 
EXPERT OPINION ON DRUG SAFETY  
Digital Object Identifier (DOI): http://dx.doi.org/10.1080/14740338.2018.1506763
Abstract: Possible relationship between drug exposure and multiple sclerosis (MS) development is insufficiently investigated, and further challenged by the incomplete understanding of MS etiopathogenesis. The study aims to investigate whether drug exposure could contribute to MS, by analyzing worldwide spontaneous reporting archives of adverse drug reaction (ADRs).
Data stato definitivo: 2019-01-02T18:27:47Z
Appare nelle tipologie:

File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
 
 
 
Powered by IRIS-about IRIS-Utilizzo dei cookie
Logo CINECA  Copyright © 2020